Alluvi tirzepatide is emerged as a promising therapeutic candidate for the treatment of metabolic diseases. This exploratory evaluation explored the efficacy and safety of tirzepatide 40mg in in vivo models of metabolic https://nikolasrdxj846041.blog5.net/84444606/preclinical-evaluation-of-alluvi-tirzepatide-40mg-for-metabolic-disease-treatment